Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

Ghotbi E, Hathaway QA, Bluemke DA, Ibad HA, Shabani M, Akhtarkhavari S, Barr RG, Post WS, Budoff M, Mathur A, Lima JAC, Demehri S. CT-derived[...]

Thummala AR, Moriarty JM, Yang EH, Natour SJ. Saddle Pulmonary Embolism: An Unlikely Finding on Transesophageal Echocardiography. JACC Case Rep. 2025 Dec 4:106305. doi: 10.1016/j.jaccas.2025.106305.[...]

Shechter A, Gupta A, Kaewkes D, Taheri H, Nagasaka T, Patel V, Suruga K, Koseki K, Koren O, Makar M, Skaf S, Patel D, Chakravarty[...]